Timing of mTORI usage and outcomes in kidney transplant recipients

The introduction of mammalian target of rapamycin inhibitors (mTORi) as immunosuppressive agents has changed the landscape of calcineurin inhibitor-based immunosuppressive regimens. However, the timing of mTORi conversion and its associated outcomes in kidney transplantation have conflicting results...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Lee-Moay, Kung, Lan-Fang, Kuo, Mei-Chuan, Huang, A-Mei, Kuo, Hung-Tien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847621/
https://www.ncbi.nlm.nih.gov/pubmed/33526978
http://dx.doi.org/10.7150/ijms.53655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847621/
https://www.ncbi.nlm.nih.gov/pubmed/33526978
http://dx.doi.org/10.7150/ijms.53655

Ejemplares similares